https://www.selleckchem.com/products/cx-5461.html
4 months (2.3-10.9) for ED-SCLC. This real-world data analysis from a large Portuguese oncology hospital demonstrates a high disease burden for patients diagnosed with SCLC, particularly those with ED, and highlights a need for more effective therapies. This real-world data analysis from a large Portuguese oncology hospital demonstrates a high disease burden for patients diagnosed with SCLC, particularly those with ED, and highlights a need for more effective therapies.The increase in frequency of multidrug-resistant bacteria worldwide
Like
Comment
Share
